PRAX Praxis Precision Medicines, Inc.

Praxis Precision Medicines, Inc. is a clinical-stage genetic neuroscience company that develops therapies for patients and families affected by complex and debilitating brain disorders. The company was founded by Kiran Reddy, David Goldstein and Steven Petrou on September 22, 2015 and is headquartered in Cambridge, MA.

$2.45
As of 06/30/2022     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/15/2020
Outstanding shares:  45,511,773
Average volume:  4,204,763
Market cap:   $108,773,137
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BNGFSD8

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.59
PS ratio:   0.00
Return on equity:   -165.89%
Net income %:   0.00%